PMID- 34399087 OWN - NLM STAT- MEDLINE DCOM- 20220209 LR - 20220209 IS - 1448-5990 (Electronic) IS - 1031-3613 (Linking) VI - 33 IP - 12 DP - 2021 Oct TI - Dexamethasone may inhibit placental growth by blocking glucocorticoid receptors via phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin and reactive oxygen species/AMP-activated protein kinase signalling pathways in human placental JEG-3 cells. PG - 700-712 LID - 10.1071/RD21048 [doi] AB - This study explored the molecular mechanism underlying the effects of dexamethasone (DEX, 1 microM) on glucose transporters (GLUT) in JEG-3 human placental choriocarcinoma cells. JEG-3 cells were treated with DEX, an expression plasmid encoding human glucocorticoid receptor alpha (GRalpha), pcDNA3.1-GRalpha, GRalpha short interference (si) RNA, LY294002, xanthine oxidase (XO)/hypoxanthine (HX), rapamycin, insulin-like growth factor (IGF) 1, N-acetylcysteine (NAC) or phosphatidic acid (PA), and cell proliferation, apoptosis, mitochondrial membrane potential (MMP), human chorionic gonadotrophin (hCG) content, human placental lactogen (hPL) content, glucose uptake, reactive oxygen species levels and signalling pathway modulation were evaluated. Treatment of JEG-3 cells with DEX (1 microM), GRalpha siRNA, LY294002 (50 microM), XO/HX (7.2 microM/36 nM) or rapamycin (80 nM) inhibited cell proliferation, induced apoptosis, significantly decreased MMP and hCG and hPL content and increased ROS levels. In addition, glucose uptake was decreased through downregulation of the mRNA and protein expression of GRalpha, GLUT1 and GLUT3. Treatment of JEG-3 cells with GRalpha siRNA, LY294002, XO/HX or rapamycin inhibited phosphorylation of phosphatidylinositol 3-kinase (PI3K), Akt, glycogen synthase kinase 3 and mammalian target of rapamycin (mTOR) and induced the phosphorylation of AMP-activated protein kinase (AMPK) and tuberous sclerosis complex 2. The effects of GRalpha overexpression and IGF1 (100 nM), NAC (5 nM) or PA (100 microM) treatment on JEG-3 cells contrasted with those of DEX treatment. DEX blocked glucose uptake by downregulating GRalpha expression, which reduced GLUT1 and GLUT3 mRNA and protein expression, which, in turn, may have inhibited the PI3K/AKT/mTOR pathway and activated the ROS/AMPK pathway. FAU - Zhan, Xin AU - Zhan X AD - Department of Obstetrics and Gynecology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. FAU - Xie, Yiran AU - Xie Y AD - Reproductive Medicine Center, Taihe Hospital, Hubei Medical University, Shiyan 442000, China. FAU - Sun, Liping AU - Sun L AD - Department of Obstetrics and Gynecology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. FAU - Si, Qi AU - Si Q AD - Department of Obstetrics and Gynecology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. FAU - Shang, Hongkai AU - Shang H AD - Department of Obstetrics and Gynecology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; and Corresponding author. Email: hongkaishang@zju.edu.cn. LA - eng PT - Journal Article PL - Australia TA - Reprod Fertil Dev JT - Reproduction, fertility, and development JID - 8907465 RN - 0 (Reactive Oxygen Species) RN - 0 (Receptors, Glucocorticoid) RN - 7S5I7G3JQL (Dexamethasone) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) SB - IM MH - AMP-Activated Protein Kinases/metabolism MH - Apoptosis/drug effects MH - Cell Line MH - Dexamethasone/*pharmacology MH - Female MH - Humans MH - Membrane Potential, Mitochondrial/drug effects MH - Phosphatidylinositol 3-Kinases/metabolism MH - Phosphorylation/drug effects MH - Placenta/*drug effects/metabolism MH - Pregnancy MH - Proto-Oncogene Proteins c-akt/metabolism MH - Reactive Oxygen Species/*metabolism MH - Receptors, Glucocorticoid/*metabolism MH - Signal Transduction/*drug effects MH - TOR Serine-Threonine Kinases/metabolism EDAT- 2021/08/17 06:00 MHDA- 2022/02/10 06:00 CRDT- 2021/08/16 20:08 PHST- 2021/02/22 00:00 [received] PHST- 2021/06/15 00:00 [accepted] PHST- 2021/08/17 06:00 [pubmed] PHST- 2022/02/10 06:00 [medline] PHST- 2021/08/16 20:08 [entrez] AID - RD21048 [pii] AID - 10.1071/RD21048 [doi] PST - ppublish SO - Reprod Fertil Dev. 2021 Oct;33(12):700-712. doi: 10.1071/RD21048.